Praxis Precision Medicines (PRAX) Stock Highlights

76.52 | +5.05%

2024-12-21 04:01:45

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firms pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinsons Disease; PRAX-562, and PRAX-222, among others.

Statistics

Range Today

71.25 79.4

Volume Today 530.7K

Range 1 Year

16.46 86.93

Volume 1 Year 72.14M

Range 3 Year

11.85 312.75

Volume 3 Year 105.14M

Range 10 Year

11.85 914.27

Volume 10 Year 111.02M

Highlights

Market Capitalization 1.45B (small)

Floating Shares 13.77M

Current Price 76.52

Price To Earnings -7.94

Price To Revenue 682.89

Price To Book 3.62

Earnings Per Share -9.48

Payout Ratio 0%

Performance

Latest +5.05%

1 Month +5.41%

3 Months +21.42%

6 Months +123.81%

1 Year +351.98%

3 Years -69.21%

5 Years -80.33%

10 Years -80.33%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.